Pregnancy after bariatric surgery: maternal and fetal risks—an expert opinion - Summary - MDSpire

Pregnancy after bariatric surgery: maternal and fetal risks—an expert opinion

  • By

  • Annunziata Lapolla

  • September 24, 2025

  • 0 min

Share

Objective:

To evaluate the maternal and fetal risks associated with pregnancy following bariatric surgery (BS) and provide comprehensive recommendations for management.

Key Findings:
  • Bariatric surgery can reduce obesity-related pregnancy risks but may introduce complications such as SGA and postpartum hemorrhage.
  • Micronutrient deficiencies are common in pregnancies post-BS, necessitating careful nutritional monitoring and management.
  • Conception within 24 months post-BS significantly increases the risk of SGA, highlighting the need for careful timing.
  • A multidisciplinary care approach is essential for managing pregnancies in women who have undergone BS, involving nutritionists and obstetricians.
Interpretation:

While bariatric surgery can improve metabolic health and fertility, it also presents unique risks that require careful management and monitoring during pregnancy.

Limitations:
  • Limited evidence on the optimal diagnostic tests for GDM in post-BS pregnancies.
  • Lack of standardized guidelines for nutritional intake in post-BS pregnancies.
Conclusion:

Effective management of pregnancy following BS requires a comprehensive, multidisciplinary approach starting in the preconception phase to mitigate risks and ensure optimal maternal and fetal outcomes.

Original Source(s)

Pregnancy after bariatric surgery: maternal and fetal risks—an expert opinion

  • by Annunziata Lapolla

  • September 24, 2025

Related Content

Metabolic and bariatric surgery in mild obesity: mid-term outcomes and safety in an Asian population

Birthweight, Childhood BMI: What Drives the Link?

Mendelian randomization analyses linked higher birthweight with greater mid-childhood height but the connection could reflect genetic factors related to skeletal growth.

GLP-1 Drugs Tied to Lower Addiction Risk

In a target-trial emulation of more than 600,000 veterans, GLP-1 RA initiators saw fewer new substance use disorders—and patients with existing SUDs had fewer overdoses, hospitalizations, and deaths.